~~<i id='55F38ED498'><strike id='55F38ED498'><tt id='55F38ED498'><pre id='55F38ED498'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：Wikipedia 2025-09-06 01:57:39 - browse：5936

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Trump indictment: Who are the 'co

hotspot

Wikipedia

hotspot

entertainment

focus

entertainment

AdobeOurunderstandingofsexhascomealongway.Aristotletheorizedthatheatduringconceptiondeterminedwhethe

WSS

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

John Green on his newest strategy for fighting tuberculosis

EPA limits use of carcinogenic gas for sterilizing medical devices

EPA limits use of carcinogenic gas for sterilizing medical devices

The high personal cost of affirmative action for Black doctors

leisure time

entertainment

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

EPA limits use of carcinogenic gas for sterilizing medical devices

Medical records are filled with copy

Trump indictment: Who are the 'co

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

After affirmative action ruling, medical educators look to 'holistic review'

Micronoma's microbiome cancer diagnostic approach under fire

New air purifier tech could be key to improving indoor air quality

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Wikipedia

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

Vertex non

Sage hopes for a blockbuster in antidepressant now before FDA

Scientists inch closer to single

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Pence says 'crackpot lawyers' told Trump what he wanted to hear

hotspot

entertainment

focus

entertainment